Tobacco Control最新文献

{"title":"Best practice for tobacco smoking policies within an acute substance use disorder care facility: considerations from a withdrawal management setting in British Columbia, Canada.","authors":"Natasha Caton, Mark Lysyshyn, Nicole Cowan, Evan Wood","doi":"10.1136/tc-2024-059134","DOIUrl":"https://doi.org/10.1136/tc-2024-059134","url":null,"abstract":"<p><p>Smoking-related illness has historically been a major cause of death in persons with substance use disorders. Smoking cessation has the potential to support improved substance use disorder outcomes, as well as improved physical and mental health outcomes in persons receiving other substance use disorder treatment. However, tobacco abstinence-oriented policies within substance use disorder care settings may create barriers to clients who are uninterested in quitting smoking being able to access other potentially lifesaving substance use disorder treatment. In British Columbia, where the drug toxicity crisis has become the leading cause of unnatural death, reducing barriers to accessing substance use disorder treatment is a key public health priority. We present a <b>reflection on considerations from a withdrawal management setting</b> of a smoking policy change within that facility and review the potential benefits and harms of permissive smoking policies within substance use disorder care environments. Benefits include the elimination of a barrier to accessing other substance use treatment, patient autonomy over participation in smoking cessation treatment and the potential for less covert smoking and associated risks. Risks include ongoing physical and mental health harms of smoking, potentially poorer other substance use treatment outcomes, risks of tobacco relapse to other clients and secondhand smoke exposure to staff and other clients. Further research will be needed to explore the impacts of this policy change and evaluate the potential role for other smoking cessation innovations, including expansion of nicotine replacement options such as provision of nicotine electronic cigarette devices.</p>","PeriodicalId":23145,"journal":{"name":"Tobacco Control","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144485905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comprehensive review of Pacific Island countries' reports on the Framework Convention on Tobacco Control (2007-2023): progress, challenges and opportunities.","authors":"Daniel Bogale Odo, Irene Semos, Odette Toloube, Melanie Pore, Vicky Wari, El-Shadan Tautolo, Raglan Maddox","doi":"10.1136/tc-2024-059251","DOIUrl":"https://doi.org/10.1136/tc-2024-059251","url":null,"abstract":"<p><strong>Objective: </strong>Consistent with the role of the WHO Framework Convention on Tobacco Control (FCTC), the aims of this study were to review the FCTC progress reports submitted by the Pacific Island Countries (PICs) and assess regional FCTC progress.</p><p><strong>Data source and extraction: </strong>We searched FCTC: (1) Global Progress Reports for any information related to PICs; and (2) country-specific reports for all PICs. All reports submitted by PICs from 2007 to 2023 were reviewed. Information such as smoking prevalence for adult and young populations by sex/gender and age, objectives, targets, legislation, regulation and policies for tobacco control were extracted.</p><p><strong>Data synthesis: </strong>Ten global progress and 69 country-specific reports from 14 PICs were reviewed. In the most recent reports, daily smoking prevalence among males ranged from 15.8% in Niue to 64.8% in Kiribati, while among females, it ranged from 1.6% in Vanuatu to 31.8% in Kiribati. Current smoking prevalence among boys and girls ranged from 10% in Marshall Islands to 43% in the Federated States of Micronesia and from 1.5% in Marshall Islands to 28.8% in Palau, respectively. Price and tax measures, along with bans on tobacco sales to and by minors, were the most reported tobacco control strategies.</p><p><strong>Conclusions: </strong>While the PICs have ratified the FCTC and made strides to fight tobacco use and its consequences, they still face significant challenges to fully implement the FCTC. Building local and regional capacity and capability to implement and monitor progress with tobacco control policies is essential to reducing tobacco-related death and disease in the PICs.</p>","PeriodicalId":23145,"journal":{"name":"Tobacco Control","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144485915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The evolution of 'light touch' medicines regulation for nicotine vaping products in Australia.","authors":"Coral E Gartner","doi":"10.1136/tc-2024-059237","DOIUrl":"https://doi.org/10.1136/tc-2024-059237","url":null,"abstract":"<p><p>Nicotine vaping products (NVPs) have never been legal to sell as consumer products in Australia. However, a substantial illicit market in NVPs developed with retailers selling these products under the pretence of retailing nicotine-free vaping products (NFVPs), which were legal to sell in most states and territories until July 2024. Australia implemented a 'light touch' medicines regulation approach for NVPs in October 2021, in response to public concerns about a growing number of young people vaping while retaining access to NVPs for smoking cessation purposes. Substantial changes to the model were made throughout 2024, including the ending of general retail sales of NFVPs, strengthening the quality requirements for NVPs and dropping the prescription requirement for low-dose (≤20 mg/mL) NVPs. There have been several challenges to encouraging uptake of the model among both consumers and health practitioners, including low acceptability, concerns about legal liability and competition with a substantial illicit NVP market. Assuming the reforms implemented federally and by the states and territories are able to effectively curtail the illicit supply, it is unclear whether current consumers who are accessing NVPs illicitly will migrate to the legal pathway or stop NVP use. Success of the medical regulatory model will depend on support from NVP manufacturers, health practitioners, the public and policy makers. Other countries who may be considering implementing a 'light touch' medicines regulation model can learn from Australia's experience.</p>","PeriodicalId":23145,"journal":{"name":"Tobacco Control","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144485916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Utilisation of waterpipe tobacco imagery in cigarette advertising: a case study of American tobacco company and RJ Reynolds tobacco company.","authors":"Seyed Mehrdad Mohammadi, Pamela M Ling, Dorie E Apollonio, Stella Bialous","doi":"10.1136/tc-2024-058896","DOIUrl":"10.1136/tc-2024-058896","url":null,"abstract":"<p><strong>Background: </strong>Tobacco companies employ various advertising methods, including immersive consumer experiences and cultural imagery, to promote their products. To our knowledge, no prior studies have explored how cigarette companies exploited perceptions of waterpipe tobacco in their marketing activities.</p><p><strong>Methods: </strong>We conducted a search of the Truth Tobacco Industry Documents Library using keywords and snowball searches. Initial terms included 'water pipe', 'hookah', 'tradition', 'culture' and 'lounge', supplemented by programme, agency and individuals' names. Findings were cross-referenced with published scientific literature and advertising archives.</p><p><strong>Results: </strong>American Tobacco Co (ATC) introduced the Waterford cigarette in 1965. The cigarette used pinchable water capsules in its filter tip, emulating the waterpipe smoking mechanism of passing smoke through water. ATC used several waterpipe tobacco elements (textual and pictorial) in Waterford cigarette advertising. RJ Reynolds (RJR) executed the Camel Casbah Programme from 1998 to 2003 to target young adult smokers. It featured smoking lounges in outdoor concert amphitheatres with VIP treatment, including greeters and 'cigarette girls', to create a 'Camelesque' environment that enhanced the 'Pleasure to Burn Experience'. The programme operated in 30 US concert venues with, averaging 600 events annually, generating over two million consumer names for RJR's database. Casbah used hookah imagery and artefacts in interior décor, stories and the design of its Exotic Blend line extension ads.</p><p><strong>Conclusions: </strong>ATC and RJR used cultural imagery related to waterpipe tobacco and hookah to promote cigarettes. Understanding these methods can help address contemporary tobacco product advertising practices using cultural artefacts.</p>","PeriodicalId":23145,"journal":{"name":"Tobacco Control","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12335350/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144485917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"How vape companies use greenwashing to bypass New Zealand's festival sponsorship bans.","authors":"Lucy Hardie, Calvin Cochran, Becky Freeman, Judith P McCool","doi":"10.1136/tc-2024-059172","DOIUrl":"https://doi.org/10.1136/tc-2024-059172","url":null,"abstract":"","PeriodicalId":23145,"journal":{"name":"Tobacco Control","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144476800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effects of oral nicotine pouches on cigarette smoking behaviour and tobacco harm exposure: a randomised pilot trial in adults.","authors":"Lisa M Fucito, Stephen R Baldassarri, Ran Wu, Ralitza Gueorguieva, Meghan E Morean, Roy S Herbst, Suchitra Krishnan-Sarin, Stephanie S O'Malley","doi":"10.1136/tc-2024-059094","DOIUrl":"10.1136/tc-2024-059094","url":null,"abstract":"<p><p>Oral nicotine pouches may have potential for smoking cessation, but scientific evidence on the effects of pouches and their constituents on smoking behaviour is limited.</p><p><strong>Design: </strong>This study was a 4-week, open-label, randomised pilot trial of nicotine pouches in 3 mg (low) or 6 mg (high) nicotine strength.</p><p><strong>Subjects: </strong>US outpatient research clinic with non-treatment seeking adults who smoke cigarettes (N=30).</p><p><strong>Interventions: </strong>Participants selected two flavours and were instructed to switch to using nicotine pouches in place of cigarettes.</p><p><strong>Main outcome measures: </strong>We compared groups on cigarettes smoked per day, pouch use and urinary levels of a tobacco-specific carcinogen (NNAL) over 4 weeks, biochemically verified 7-day point prevalence smoking abstinence at week 4, and willingness to continue pouch use.</p><p><strong>Results: </strong>Nearly all participants completed the trial (29/30). Participants in both groups significantly reduced their cigarettes smoked per day (log-transformed) over time (F_{3, 74.4}=3.8, p=0.01). The 6 mg group reported numerically greater, but non-significant, reductions in smoking than the 3 mg group (least-square mean difference (LSMD) at week 1=0.008; 95% CI -0.42-0.44; LSMD at week 4=0.38; 95%<i> </i>CI -0.06-0.81). The 6 mg group also reported numerically higher, but non-significant, likelihood of complete smoking abstinence (13% vs 0%) and willingness to continue pouch use (67% vs 40%). There were no differences by group or time for NNAL.</p><p><strong>Conclusions: </strong>Results provide preliminary support for nicotine pouches for cigarette substitution. Compared with lower nicotine strength pouches, higher nicotine strength pouches may have a greater impact on smoking behaviour and adults who smoke may be more willing to use them.</p><p><strong>Trial registration number: </strong>NCT04250727.</p>","PeriodicalId":23145,"journal":{"name":"Tobacco Control","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12377922/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144476799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Trends in menthol and non-menthol cigarette consumption in the US: 2009-2024.","authors":"Cristine D Delnevo, Daniel P Giovenco, Andrea C Villanti","doi":"10.1136/tc-2025-059408","DOIUrl":"10.1136/tc-2025-059408","url":null,"abstract":"","PeriodicalId":23145,"journal":{"name":"Tobacco Control","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144326894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A hopeful journey: responses to efficacy labels from people using RYO tobacco in Aotearoa New Zealand.","authors":"Lani Teddy, Ellen Ozarka, Mei-Ling Blank, Andrew Waa, Janet Hoek","doi":"10.1136/tc-2024-059164","DOIUrl":"https://doi.org/10.1136/tc-2024-059164","url":null,"abstract":"<p><strong>Introduction: </strong>Although many countries have introduced pictorial warning labels (PWLs), few use efficacy labels or inserts offering supportive cessation advice or outlining benefits of quitting. Theory and evidence suggest efficacy labels foster positive responses to the threats presented rather than elicit maladaptive responses that manage the fear aroused. We explored how people who smoke roll-your-own (RYO) tobacco responded to potential on-pack efficacy labels that could complement PWLs by promoting self-efficacy and response-efficacy.</p><p><strong>Methods: </strong>We undertook 27 in-depth interviews with people aged 18 and over (16 female, 8 Māori, 13 aged ≤35) who smoked RYO cigarettes and lived in Aotearoa New Zealand. We probed participants' responses to efficacy labels and provided them with stimuli they could use to construct their own inspiring label. We used the Extended Parallel Process Model and hope theory to interpret the data, which we analysed using a reflexive thematic analysis approach.</p><p><strong>Results: </strong>Participants strongly endorsed efficacy labels; unlike current warning labels, which they saw as didactic and judgemental, efficacy labels offered hope and agency, and helped them envisage the benefits of becoming smokefree. Creating hope valued and empowered participants, while practical advice offered helped them anticipate how they could overcome addiction and become smokefree.</p><p><strong>Conclusions: </strong>On-pack efficacy labels could complement PWLs and support people to address the threat these warnings describe. Policymakers should explore and implement interventions such as efficacy stimuli, given these appear to resonate with priority population groups and could help reduce health inequities.</p>","PeriodicalId":23145,"journal":{"name":"Tobacco Control","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144326880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Model-based appraisal of the potential effects of minimum pricing for tobacco in Scotland.","authors":"Duncan Gillespie, Damon Morris, Colin Angus, Luke B Wilson, Ryan Kai Le Chen, Grace Leeming, John Holmes, Alan Brennan","doi":"10.1136/tc-2024-059252","DOIUrl":"https://doi.org/10.1136/tc-2024-059252","url":null,"abstract":"<p><strong>Background: </strong>Minimum tobacco pricing would set a legal price floor. This study aimed to estimate how five minimum price thresholds could impact smoking behaviour, health and economic outcomes alongside tobacco tax increases in Scotland.</p><p><strong>Methods: </strong>The Sheffield Tobacco and Alcohol Policy Model was used to estimate effects on tobacco consumption up to the Scottish Government's 'tobacco-free' target of 2034. The model is an individual-based microsimulation that uses data from the Scottish Health Survey, Living Costs and Food Survey, hospital and death records. The £0.40 and £0.50 per cigarette stick minimum prices would impact only hand-rolling tobacco (assuming 0.5 g hand-rolling tobacco per cigarette), and the £0.60, £0.70 and £0.80 per stick minimums would affect hand-rolling and factory-made cigarettes.</p><p><strong>Results: </strong>A £0.60 minimum implemented in 2024 was estimated to lead to 16 327 fewer people who smoke and increase weekly tobacco spending by £7.21 for those who continue smoking. It would prevent an estimated 285 deaths, adding 6792 life years, and reducing hospital admissions by 1467 by 2034. These health gains would be higher in more deprived geographic areas, saving the Scottish National Health Service £1.2 million over 5 years and £2.7 million by 2034. Over 5 years, a £0.60 minimum price would reduce UK Government tax revenue by £253 million, while increasing tobacco industry revenue by £996 million.</p><p><strong>Conclusions: </strong>A minimum price implemented alongside tobacco duty rises could reduce smoking rates and improve public health, especially for those living in deprived areas where smoking rates and related harms are highest.</p>","PeriodicalId":23145,"journal":{"name":"Tobacco Control","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144326893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Changes in seeking smoking cessation therapy among Japanese employees and their families: a possible role for the dissemination of heated tobacco products (HTPs).","authors":"Chie Taniguchi, Isao Oze, Akihiko Narisada, Rei Wakayama, Akiyo Nonogaki, Hideo Tanaka, Kohta Suzuki","doi":"10.1136/tc-2025-059331","DOIUrl":"https://doi.org/10.1136/tc-2025-059331","url":null,"abstract":"<p><strong>Introduction: </strong>The adoption of heated tobacco products (HTPs) has grown as smokers transition away from conventional cigarettes for harm reduction. However, the impact of HTP use on smoking behaviours remains unclear.</p><p><strong>Methods: </strong>We analysed data from 8890 records of smokers seeking smoking cessation therapy (SCT) between 2014 and 2019 using the Japan Medical Data Center claims database. September 2015, when the HTP 'IQOS' was launched in 12 major prefectures in Japan, marked the first dissemination phase of HTP. April 2016, when IQOS became available nationwide, marked the second phase. Interrupted time series analysis was applied to evaluate changes in SCT uptake rates across these phases.</p><p><strong>Results: </strong>Following the first dissemination phase, there was a significant immediate decrease in SCT uptake (-0.21%, 95% CI: -0.41% to -0.16%, p=0.035), followed by a further significant reduction after the second phase (-0.26%, 95% CI: -0.48% to -0.10%, p=0.008). Additionally, the slope of SCT uptakes was significantly decreased after the second phase (-0.007% per month, 95% CI: -0.012 to -0.02, p=0.008).</p><p><strong>Conclusions: </strong>Our study showed that SCT uptake decreased sharply when HTPs were disseminated to all prefectures in Japan, and this downward trend continued thereafter. These findings are considered to result from the widespread adoption of HTP in the Japanese market, as these products were perceived to be less harmful than traditional cigarettes. Therefore, it is worrying that the widespread availability of HTP resulted in reduced smoking cessation behaviour among cigarette users.</p>","PeriodicalId":23145,"journal":{"name":"Tobacco Control","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144326881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}